PACS Group, Inc. (PACS) Key Metrics
PACS valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $7.43B
- Enterprise value
- $9.59B
- P/E (TTM)
- 27.4
- Forward P/E
- 15.5
- PEG ratio
- 1.03
- Price / sales
- 1.3
- Price / book
- 5.9
- EV / EBITDA
- 20.0
- Dividend yield
- —
- Beta
- −0.08
PACS key metrics, 2021–2025
Fiscal year ended December 31, 2025 · U.S. dollarsPACS valuation Price multiples at each fiscal year-end price.
PACS returns How much profit the business earns on the capital it uses.
PACS per-share figures Results divided by the shares outstanding at year-end.
PACS financial health Debt, liquidity and how easily interest is covered.
PACS efficiency & capital use Working capital cycle and where the cash goes.
PACS valuation history
PACS returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
PACS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
PACS cash returned to shareholders
PACS price vs earnings per share
PACS key metrics
2021–2025| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $6.02B | $2.03B | — | — | — |
| Enterprise value | $9.29B | $2.13B | — | — | — |
| P/E ratio | 31.4 | 36.5 | — | — | — |
| Price / sales | 1.1 | 0.5 | — | — | — |
| Price / book | 6.4 | 2.8 | — | — | — |
| Price / free cash flow | 20.1 | 116.0 | — | — | — |
| Price / operating cash flow | 14.9 | 5.5 | — | — | — |
| EV / sales | 1.8 | 0.5 | — | — | — |
| EV / EBITDA | 25.4 | 11.4 | — | — | — |
| EV / free cash flow | 31.1 | 121.4 | — | — | — |
| Earnings yield | 3.2% | 2.7% | — | — | — |
| Free cash flow yield | 5.0% | 0.9% | — | — | — |
| Dividend yield | 0.6% | 1.7% | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.6% | 1.7% | — | — | — |
| Share price at fiscal year-end | $38.39 | $13.11 | — | — | — |
| Per share | |||||
| Revenue per share | $33.75 | $26.36 | $20.72 | $16.13 | $7.77 |
| Earnings per share | $1.22 | $0.36 | $0.75 | $1.00 | $0.32 |
| Operating cash flow per share | $2.58 | $2.37 | $0.42 | $0.62 | $0.38 |
| Free cash flow per share | $1.91 | $0.11 | $0.12 | $0.46 | −$0.44 |
| Cash per share | $1.26 | $1.02 | $0.49 | $0.39 | — |
| Book value per share | $6.04 | $4.61 | $0.64 | $0.42 | — |
| Tangible book value per share | $5.61 | $4.18 | $0.21 | $0.01 | — |
| Dividends per share | $0.22 | $0.22 | $0.54 | $0.40 | $0.36 |
| Capex per share | $0.67 | $2.25 | $0.30 | $0.15 | $0.83 |
| Debt per share | $22.15 | $1.62 | $18.68 | $12.82 | — |
| Shares outstanding | 156.7M | 155.2M | 150.2M | 150.2M | 150.2M |
| Change in shares outstanding | +1.0% | +3.3% | 0.0% | 0.0% | — |
| Returns & profitability | |||||
| Return on equity (ROE) | 23.0% | 13.7% | 141.3% | 236.5% | — |
| Return on invested capital (ROIC) | 8.3% | 5.3% | 6.3% | 8.6% | — |
| Return on assets (ROA) | 3.5% | 1.3% | 3.8% | 6.1% | — |
| Return on tangible assets | 3.5% | 1.1% | 3.3% | 6.3% | — |
| Free cash flow margin | 5.6% | 0.4% | 0.6% | 2.9% | −5.7% |
| Income quality (OCF / net income) | 2.11 | 6.59 | 0.56 | 0.62 | 1.20 |
| Financial health | |||||
| Total debt | $3.47B | $251.0M | $2.80B | $1.93B | — |
| Cash & short-term investments | $197.0M | $157.7M | $73.4M | $58.3M | — |
| Net debt | $3.27B | $93.3M | $2.73B | $1.87B | — |
| Debt / equity | 3.67 | 0.35 | 29.18 | 30.25 | — |
| Debt / assets | 0.62 | 0.05 | 0.80 | 0.78 | — |
| Net debt / EBITDA | 8.96 | 0.50 | 11.73 | 7.33 | — |
| Current ratio | 1.07 | 0.96 | 1.58 | 1.06 | — |
| Quick ratio | 1.07 | 0.96 | 1.58 | 1.06 | — |
| Interest coverage | 10.9 | 2.8 | 4.2 | 9.0 | 15.8 |
| Working capital | $68.3M | −$40.2M | $265.2M | $27.3M | — |
| Invested capital | $4.22B | $809.0M | $2.83B | $1.93B | — |
| Tangible asset value | $884.4M | $648.6M | $36.4M | $7.2M | — |
| Net current asset value | −$3.56B | −$3.59B | −$2.69B | −$1.88B | — |
| Graham number | $12.89 | $6.11 | $3.29 | $3.09 | — |
| Graham net-net per share | −$24.94 | −$25.06 | −$19.23 | −$13.45 | — |
| Capital allocation | |||||
| Dividends paid | $33.7M | $33.7M | $80.4M | $60.3M | $53.8M |
| Dividend payout ratio | 17.6% | 60.5% | 71.2% | 40.1% | 112.2% |
| Dividends + buybacks / free cash flow | 11.3% | 192.3% | 448.8% | 86.4% | — |
| Capex / revenue | 2.0% | 8.6% | 1.5% | 0.9% | 10.6% |
| Capex / operating cash flow | 26.1% | 95.2% | 71.9% | 24.7% | 215.4% |
| Capex / depreciation | 1.89 | 8.57 | 1.79 | 1.02 | 17.35 |
| Stock-based compensation / revenue | 1.0% | 2.8% | 0.0% | 0.0% | — |
| SG&A / revenue | 7.8% | 8.4% | 6.9% | 6.2% | 8.3% |
| Efficiency | |||||
| Days sales outstanding | 46.4 | 55.4 | 59.8 | 63.3 | — |
| Days of inventory on hand | — | — | 0.0 | — | — |
| Days payables outstanding | 16.2 | 16.1 | 17.2 | 20.0 | — |
| Cash conversion cycle (days) | 30.1 | 39.3 | 42.6 | 43.3 | — |
| Receivables turnover | 7.87 | 6.59 | 6.10 | 5.76 | — |
| Payables turnover | 22.49 | 22.67 | 21.19 | 18.28 | — |
| Inventory turnover | — | — | 2,664,424,000.00 | — | — |
| Asset turnover | 0.98 | 0.93 | 1.04 | 0.98 | — |
| Average receivables | $671.9M | $620.9M | $510.1M | $420.1M | — |
| Average payables | $183.6M | $158.0M | $125.8M | $110.6M | — |
| Average inventory | — | — | $1 | — | — |
| Intangibles / total assets | 1.2% | 1.3% | 1.9% | 2.5% | — |
Computed from PACS's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
PACS valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), PACS traded at 31.4 times earnings. Based on the latest twelve months, the trailing P/E is 27.4 and the forward P/E is 15.5. PACS earned a return on equity of 23.0% and a return on invested capital of 8.3% in fiscal 2025. It ended the year with $3.5 billion of debt and $197.0 million in cash and short-term investments, net debt of $3.3 billion. It returned $33.7 million to shareholders: $33.7 million in dividends and $0 in share buybacks, 11% of free cash flow. The share count rose 4.4% from 150.2M to 156.7M over 4 years.
See the PACS income statement, the PACS chart for price history, or the PACS stock overview for the latest quote and news.
PACS key metrics FAQ
What is PACS's P/E ratio?
PACS's trailing P/E ratio is 27.4 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 15.5. At the end of fiscal 2025 it was 31.4.
What is PACS's EV/EBITDA?
PACS's enterprise value was 25.4 times EBITDA at the end of fiscal 2025 (enterprise value $9.3 billion, EBITDA $365.6 million); the current EV/EBITDA is 20.0.
What is PACS's return on equity?
PACS's return on equity (ROE) was 23.0% in fiscal 2025: net income of $191.5 million on average shareholders' equity of $831.2 million.
What is PACS's ROIC?
PACS's return on invested capital was 8.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does PACS have?
PACS had total debt of $3.5 billion at the end of fiscal 2025, a debt-to-equity ratio of 3.67 and $3.3 billion of net debt (8.96 times EBITDA).
What is PACS's dividend yield?
PACS paid $33.7 million in dividends in fiscal 2025 ($0.22 per share), a payout ratio of 17.6%.
What is PACS's free cash flow yield?
PACS generated $298.8 million of free cash flow in fiscal 2025, a free cash flow yield of 5.0% on its market value at year-end ($6.0 billion).
What is PACS's current ratio?
PACS's current ratio was 1.07 at the end of fiscal 2025: current assets were 1.07 times current liabilities.